Drug Information
Drug (ID: DG01777) and It's Reported Resistant Information
| Name |
Oxygen
|
||||
|---|---|---|---|---|---|
| Synonyms |
7782-44-7; O; Oxygen; Molecular oxygen; oxygen molecule; Dioxygen; Pure oxygen; Oxygenium; Liquid oxygen; Hyperoxia; Sauerstoff; Oxygen-16; Oxygen (liquid); Oxygen, liquified; Oxygenium medicinale; oxygene; CCRIS 1228; HSDB 5054; O2; UN1072; UN1073; UNII-S88TT14065; Peroxide Ion; CHEBI:15379; S88TT14065; LOX; E948; E-948; Oxygene [French]; Oxigeno [Spanish]; OXY; Compressed oxygen; Oxygen [USP]; EINECS 231-956-9; dioxidanediyl; dioxygene; Disauerstoff; oxygen monoxide; Peroxy radical; singlet dioxygen; triplet dioxygen; Oxygen USP; Oxygen, compressed; Oxygen 93 percent; singlet molecular oxygen; triplet molecular oxygen; Oxygen (8CI,9CI); Oxygen (JP17/USP); dioxygen(2.) (triplet); Oxygen, >=99.6%; Oxygen, compressed [UN1072] [Nonflammable gas]; RNS60 COMPONENT OXYGEN; [OO]; INS NO.948; Oxygen, >=99.998%; CHEMBL1234886; DTXSID2037681; RNS-60 COMPONENT OXYGEN; CHEBI:26689; CHEBI:27140; INS-948; Oxygen, refrigerated liquid (cryogenic liquid) [UN1073] [Nonflammable gas]; DB09140; UN 1072; UN 1073; Oxygen, Messer(R) CANGas, 99.999%; DS-014940; (1)O2; E 948; C00007; D00003; O2(2.); Oxygen, refrigerated liquid (cryogenic liquid); Oxygen, compressed [UN1072] [Nonflammable gas]; (O2)(..); (O2)(2.); Q5203615; UNII-K21NZZ5Y0B component MYMOFIZGZYHOMD-UHFFFAOYSA-N; AQUANAL(TM)-plus oxygen (O2) 1-12 mg/L, refill pack for 37428; AQUANAL(TM)-plus oxygen (O2) 1-12 mg/L, test set with color comparator; 4-Chloro-3-(chloro-difluoro-methyl)-4,4-difluoro-1-thiophen-2-yl-but-2-en-2-one; Oxygen, refrigerated liquid (cryogenic liquid) [UN1073] [Nonflammable gas]
Click to Show/Hide
|
||||
| Structure |
|
||||
| Drug Resistance Disease(s) |
Disease(s) with Resistance Information Validated by in-vivo Model for This Drug
(1 diseases)
[1]
|
||||
| Target | . | NOUNIPROTAC | [1] | ||
| Click to Show/Hide the Molecular Information and External Link(s) of This Drug | |||||
| IsoSMILES |
O=O
|
||||
| InChI |
InChI=1S/O2/c1-2
|
||||
| InChIKey |
MYMOFIZGZYHOMD-UHFFFAOYSA-N
|
||||
| PubChem CID | |||||
Type(s) of Resistant Mechanism of This Drug
Drug Resistance Data Categorized by Their Corresponding Diseases
ICD-25: Uncertain aetiology/emergency use
| Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
|
|
||||
| Key Molecule: Maternally expressed 3 (MEG3) | [1] | |||
| Molecule Alteration | Down-regulation | Interaction |
||
| Resistant Disease | Lung damage [ICD-11: RA00] | |||
| Experimental Note | Discovered Using In-vivo Testing Model | |||
| In Vitro Model | MLE-12 cells | Lung | Mus musculus (Mouse) | CVCL_3751 |
| In Vivo Model | MEG3 knockdown mice model | Mus musculus | ||
| Experiment for Molecule Alteration |
Knockdown assay; qRT-PCR; Western bloting analysis; Luciferase assay; ELISA assay | |||
| Experiment for Drug Resistance |
MTT assay; LDH assay; Flow cytometry assay; HE staining assay | |||
| Mechanism Description | Knockdown of MEG3 inhibits pyroptosis to alleviate hyperoxia lung injury by suppressing NLRP3 inflammasome and caspase-1 signaling via regulating miR-18a-TXNIP axis. | |||
References
visits since 2022
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.
